| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Mural Oncology plc (NASDAQ:MURA) ("Mural") today announced that its shareholders have voted to approve the previously a...
																	
																	
																	
																	Mural Oncology (NASDAQ:MURA) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1....
																	
Shares of Mural Oncology plc (NASDAQ: MURA) are soaring Monday following the company's announcement that it will discontinu...